Responsiveness and minimal important difference of the urticaria control test

被引：73

作者：

Ohanyan, Tatevik ^{[1
]}

Schoepke, Nicole ^{[1
]}

Bolukbasi, Bediha ^{[1
]}

Metz, Martin ^{[1
]}

Hawro, Tomasz ^{[1
]}

Zuberbier, Torsten ^{[1
]}

Peveling-Oberhag, Adriane ^{[2
]}

Staubach, Petra ^{[2
]}

Maurer, Marcus ^{[1
]}

Weller, Karsten ^{[1
]}

机构：

[1] Charite Univ Med Berlin, Dept Dermatol & Allergy, Allergie Ctr Charite, Berlin, Germany

[2] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 140卷 / 06期

关键词：

QUALITY-OF-LIFE; OMALIZUMAB; VALIDATION; MANAGEMENT; INDEX;

D O I：

10.1016/j.jaci.2017.04.050

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：1710 / +

页数：15

共 25 条

[1] A new tool to evaluate the impact of chronic urticaria on quality of life:: chronic urticaria quality of life questionnaire (CU-Q2oL) [J].

Baiardini, I ;

Pasquali, M ;

Braido, F ;

Fumagalli, F ;

Guerra, L ;

Compalati, E ;

Braga, M ;

Lombardi, C ;

Fassio, O ;

Canonica, GW .

ALLERGY, 2005, 60 (08) :1073-1078

[2] Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA2LEN taskforce position paper [J].

Baiardini, I. ;

Braido, F. ;

Bindslev-Jensen, C. ;

Bousquet, P. J. ;

Brzoza, Z. ;

Canonica, G. W. ;

Compalati, E. ;

Fiocchi, A. ;

Fokkens, W. ;

van Wijk, R. Gerth ;

Gimenez-Arnau, A. ;

Godse, K. ;

Grattan, C. ;

Grob, J. J. ;

La Grutta, S. ;

Kalogeromitros, D. ;

Kocaturk, E. ;

Lombardi, C. ;

Mota-Pinto, A. ;

Ridolo, E. ;

Saini, S. S. ;

Sanchez-Borges, M. ;

Senna, G. E. ;

Terreehorst, I. ;

Bom, A. Todo ;

Toubi, E. ;

Bousquet, J. ;

Zuberbier, T. ;

Maurer, M. .

ALLERGY, 2011, 66 (07) :840-844

[3]

de Vet HC, 2011, MEASUREMENT MED PRAC, P241

[4] The minimal detectable change should not replace the minimal important difference [J].

de Vet, Henrica C. W. ;

Terwee, Caroline B. .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 2010, 63 (07) :804-805

[5] ASSESSING THE RESPONSIVENESS OF FUNCTIONAL SCALES TO CLINICAL-CHANGE - AN ANALOGY TO DIAGNOSTIC-TEST PERFORMANCE [J].

DEYO, RA ;

CENTOR, RM .

JOURNAL OF CHRONIC DISEASES, 1986, 39 (11) :897-906

[6] DERMATOLOGY LIFE QUALITY INDEX (DLQI) - A SIMPLE PRACTICAL MEASURE FOR ROUTINE CLINICAL USE [J].

FINLAY, AY ;

KHAN, GK .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1994, 19 (03) :210-216

[7] DETERMINING A MINIMAL IMPORTANT CHANGE IN A DISEASE-SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE [J].

JUNIPER, EF ;

GUYATT, GH ;

WILLAN, A ;

GRIFFITH, LE .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (01) :81-87

[8] Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy [J].

Kaplan, Allen ;

Ledford, Dennis ;

Ashby, Mark ;

Canvin, Janice ;

Zazzali, James L. ;

Conner, Edward ;

Veith, Joachim ;

Kamath, Nikhil ;

Staubach, Petra ;

Jakob, Thilo ;

Stirling, Robert G. ;

Kuna, Piotr ;

Berger, William ;

Maurer, Marcus ;

Rosen, Karin .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 132 (01) :101-109

[9] Disease Activity Only Moderately Correlates with Quality of Life Impairment in Patients with Chronic Spontaneous Urticaria [J].

Koti, I. ;

Weller, K. ;

Makris, M. ;

Tiligada, E. ;

Psaltopoulou, T. ;

Papageorgiou, C. ;

Baiardini, I. ;

Panagiotakos, D. ;

Braido, F. ;

Maurer, M. .

DERMATOLOGY, 2013, 226 (04) :371-379

[10] Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life [J].

Lennox, RD ;

Leahy, MJ .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 93 (02) :142-146

← 1 2 3 →